K. Zheng

Time Severity for AKI Time Severity for Glucose Severity for CKD Stage I Time Severity for Diabetes Time

K. Zheng, 2017 .

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing

J. T. ten Berg, J. Kelder, K. Zheng, 2021, Research and practice in thrombosis and haemostasis.

Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review.

J. T. ten Berg, H. ten Cate, L. Boersma, 2022, Thrombosis research.

Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction.

C. Granger, B. Coller, C. Gibson, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) study.

J. T. ten Berg, K. Zheng, C. Hackeng, 2022, Thrombosis research.

Measuring high on-treatment platelet reactivity in clinical practice should we use a panel of platelet function tests?

J. T. ten Berg, B. Zwart, J. Kelder, 2019, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction – A post hoc analysis of the cel-02 phase IIa study

C. Gibson, O. Bentur, K. Zheng, 2023, American heart journal.

The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions

J. T. ten Berg, D. Aradi, K. Zheng, 2021, Platelets.